← Back to home

ADVANCED SOLID TUMOR, SCLC(SMALL CELL LUNG CANCER) OR LCNEC (LARGE CELL NEUROENDOCRINE CARCINOMA)

Clinical trials for ADVANCED SOLID TUMOR, SCLC(SMALL CELL LUNG CANCER) OR LCNEC (LARGE CELL NEUROENDOCRINE CARCINOMA) explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SOLID TUMOR, SCLC(SMALL CELL LUNG CANCER) OR LCNEC (LARGE CELL NEUROENDOCRINE CARCINOMA) trials appear

Sign up with your email to follow new studies for ADVANCED SOLID TUMOR, SCLC(SMALL CELL LUNG CANCER) OR LCNEC (LARGE CELL NEUROENDOCRINE CARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First patients receive experimental cancer drug in new trial

Disease control Recruiting now

This is the first study in people to test a new drug called FZ-AD005. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs that it might help shrink tumors in patients with advanced cancers, particularly certai…

Matched conditions: ADVANCED SOLID TUMOR, SCLC(SMALL CELL LUNG CANCER) OR LCNEC (LARGE CELL NEUROENDOCRINE CARCINOMA)

Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 09, 2026 14:25 UTC

ADVANCED SOLID TUMOR, SCLC(SMALL CELL LUNG CANCER) OR LCNEC (LARGE CELL NEUROENDOCRINE CARCINOMA)

Get alerted when new ADVANCED SOLID TUMOR, SCLC(SMALL CELL LUNG CANCER) OR LCNEC (LARGE CELL NEUROENDOCRINE CARCINOMA) trials appear

First patients receive experimental cancer drug in new trial